Dietary restrictions in dialysis patients: is there anything left to eat?

K Kalantar‐Zadeh, AR Tortorici, JLT Chen… - Seminars in …, 2015 - Wiley Online Library
A significant number of dietary restrictions are imposed traditionally and uniformly on
maintenance dialysis patients, whereas there is very little data to support their benefits …

Haemodialysis-induced hypoglycaemia and glycaemic disarrays

M Abe, K Kalantar-Zadeh - Nature Reviews Nephrology, 2015 - nature.com
In patients with diabetes receiving chronic haemodialysis, both very high and low glucose
levels are associated with poor outcomes, including mortality. Conditions that are associated …

[HTML][HTML] Nutrition intervention for advanced stages of diabetic kidney disease

J Goldstein-Fuchs, K Kalantar-Zadeh - Diabetes spectrum: a …, 2015 - ncbi.nlm.nih.gov
IN BRIEF For the goals of reducing diabetic kidney disease (DKD) onset and progression,
approaches to nutritional therapy are a subject of much debate. This article discusses …

Relaxin inhibits high glucose-induced matrix accumulation in human mesangial cells by interfering with TGF-β1 production and mesangial cells phenotypic transition

X Xie, W Xia, X Fei, Q Xu, X Yang, D Qiu… - Biological and …, 2015 - jstage.jst.go.jp
Diabetic nephropathy (DN) is the leading cause of end-stage renal disease (ESRD). DN is
characterized by glomerular extracellular matrix accumulation, mesangial expansion …

[HTML][HTML] Cross-sectional examination of metabolites and metabolic phenotypes in uremia

S Kalim, CB Clish, JJ Deferio, G Ortiz, AS Moffet… - BMC nephrology, 2015 - Springer
Background Although metabolomic approaches have begun to document numerous
changes that arise in end stage renal disease (ESRD), how these alterations relate to …

[PDF][PDF] Metformin in chronic kidney disease: more harm than help?

K Kalantar-Zadeh, CM Rhee - The Lancet Diabetes and …, 2015 - escholarship.org
Drug regulatory agencies in countries around the world have issued specific warnings and
restrictions pertaining to the use of metformin in patients with chronic kidney disease (CKD) …

[HTML][HTML] Взаимосвязь вариабельности уровня глюкозы и функции почек у больных сахарным диабетом 2 типа на базис-болюсной инсулинотерапии

ВВ Климонтов, НЕ Мякина - Сахарный диабет, 2015 - cyberleninka.ru
Цель. Определить взаимосвязь вариабельности уровня глюкозы (ВГ) с функцией почек
у больных сахарным диабетом 2 типа (СД2), получающих базис-болюсную …

Restricting metformin in CKD: continued caution warranted

CM Rhee, K Kalantar-Zadeh - American Journal of Kidney Diseases, 2015 - ajkd.org
Given the low observed incidence of metformin-associated lactic acidosis (MALA) in a
systematic review of diabetic patients with and without CKD, 1 a commentary by Stanton 2 …

Bicarbonate dialysis compared to hemodiafiltration on glycemic excursions in patients with end-stage renal disease with and without type 2 diabetes mellitus

G Derosa, C Libetta, P Esposito, I Borettaz… - Journal of Diabetes and …, 2015 - Elsevier
Aim To evaluate the effects on glycemic excursions during bicarbonate dialysis (BHD)
compared to hemodiafiltration (HDF) in type 2 diabetic or not diabetic patients affected by …

[HTML][HTML] The relationships between glucose variability and renal function in type 2 diabetes patients on basal-bolus insulin therapy

VV Klimontov, NE Myakina - Diabetes mellitus, 2015 - dia-endojournals.ru
Aim. To assess the relationship of glucose variability (GV) and renal function in patients with
type 2 diabetes on basal-bolus insulin therapy. Materials and methods. We observed 101 …